These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2099404)

  • 1. Evidence that the B lymphocyte proliferating in B-CLL and in other B-cell malignancies is frequently committed to production of natural autoantibodies.
    Dighiero G; Borche L
    Nouv Rev Fr Hematol (1978); 1990; 32(5):323-6. PubMed ID: 2099404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basic biology of autoimmune phenomena in chronic lymphocytic leukemia.
    Pritsch O; Maloum K; Dighiero G
    Semin Oncol; 1998 Feb; 25(1):34-41. PubMed ID: 9482525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmunity and B-cell malignancies.
    Dighiero G
    Verh Dtsch Ges Pathol; 1996; 80():148-59. PubMed ID: 9020570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmunity and B-cell malignancies.
    Dighiero G
    Hematol Cell Ther; 1998 Feb; 40(1):1-9. PubMed ID: 9556183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoglobulin genes in chronic lymphocytic leukemia.
    Kipps TJ
    Blood Cells; 1993; 19(3):615-25; discussion 631-2. PubMed ID: 8018942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibody activity and V gene usage by B-cell malignancies.
    Dighiero G
    Leuk Lymphoma; 1992 Nov; 8(4-5):345-51. PubMed ID: 1283965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different levels of CD52 antigen expression evaluated by quantitative fluorescence cytometry are detected on B-lymphocytes, CD 34+ cells and tumor cells of patients with chronic B-cell lymphoproliferative diseases.
    Klabusay M; Sukova V; Coupek P; Brychtova Y; Mayer J
    Cytometry B Clin Cytom; 2007 Sep; 72(5):363-70. PubMed ID: 17428002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B-chronic lymphocytic leukemia, small lymphocytic lymphoma, and lymphoplasmacytic lymphoma, including Waldenström's macroglobulinemia: a clinical, morphologic, and biologic spectrum of similar disorders.
    Pangalis GA; Angelopoulou MK; Vassilakopoulos TP; Siakantaris MP; Kittas C
    Semin Hematol; 1999 Apr; 36(2):104-14. PubMed ID: 10319379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct cellular interaction with activated CD4(+) T cells overcomes hyporesponsiveness of B-cell chronic lymphocytic leukemia in vitro.
    Tretter T; Schuler M; Schneller F; Brass U; Esswein M; Aman MJ; Huber C; Peschel C
    Cell Immunol; 1998 Oct; 189(1):41-50. PubMed ID: 9758693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of proliferation marker Ki 67 in chronic lymphocytic leukemia].
    Diop S; Letestu R; Orsolani D; Leboeuf Y; Le Tutour P; Thiam D; Diakhate L; Valensi F
    Dakar Med; 2005; 50(2):65-8. PubMed ID: 16295759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does the CLL B lymphocyte correspond to expansion of an immature B clone or to expansion of a distinct subpopulation of B cells?
    Dighiero G; Binet JL
    Blood Cells; 1987; 12(2):385-97. PubMed ID: 3113518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgVH mutational status and clonality analysis of Richter's transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution.
    Mao Z; Quintanilla-Martinez L; Raffeld M; Richter M; Krugmann J; Burek C; Hartmann E; Rudiger T; Jaffe ES; Müller-Hermelink HK; Ott G; Fend F; Rosenwald A
    Am J Surg Pathol; 2007 Oct; 31(10):1605-14. PubMed ID: 17895764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B Cell Malignancies Frequently Target the Autoreactive B Cell Repertoire.
    Dighiero G; Borche L
    Leuk Lymphoma; 1991; 5 Suppl 1():47-51. PubMed ID: 27463479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B cell malignancies frequently reflect expansion of the autoreactive B cell repertoire, although the mechanism accounting for this remains controversial.
    Dighiero G
    Blood Cells; 1993; 19(3):626-30; discussion 631-2. PubMed ID: 8018943
    [No Abstract]   [Full Text] [Related]  

  • 15. Monoclonal antibody studies in B(non-T)-cell malignancies.
    Shimoyama M; Minato K; Tobinai K; Nagai M; Hirose M
    Jpn J Clin Oncol; 1983 Sep; 13(3):477-88. PubMed ID: 6417373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activation of leukaemic B cells by interleukin-4 and antibodies to CD40.
    Crawford DH; Catovsky D
    Immunology; 1993 Sep; 80(1):40-4. PubMed ID: 7503945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigens in chronic lymphocytic leukemia--implications for cell origin and leukemogenesis.
    Rosén A; Murray F; Evaldsson C; Rosenquist R
    Semin Cancer Biol; 2010 Dec; 20(6):400-9. PubMed ID: 20863893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-13 has only a subset of IL-4-like activities on B chronic lymphocytic leukaemia cells.
    Fluckiger AC; Brière F; Zurawski G; Bridon JM; Banchereau J
    Immunology; 1994 Nov; 83(3):397-403. PubMed ID: 7530690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pathogenesis of chronic lymphocytic leukemia: analysis of the antibody repertoire.
    Schroeder HW; Dighiero G
    Immunol Today; 1994 Jun; 15(6):288-94. PubMed ID: 7520700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GM-CSF does not increase CD20 antigen expression on chronic lymphocytic leukemia lymphocytes.
    Yağci M; Akar I; Sucak GT; Haznedar R
    Leuk Res; 2005 Jul; 29(7):735-8. PubMed ID: 15927668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.